MDM2 Antibody
- Known as:
- MDM2 Antibody
- Catalog number:
- XW-7367
- Product Quantity:
- 0.05 mg
- Category:
- -
- Supplier:
- Prosci
- Gene target:
- MDM2 Antibody
Ask about this productRelated genes to: MDM2 Antibody
- Gene:
- MDM2 NIH gene
- Name:
- MDM2 proto-oncogene
- Previous symbol:
- -
- Synonyms:
- HDM2, MGC5370
- Chromosome:
- 12q15
- Locus Type:
- gene with protein product
- Date approved:
- 1993-12-10
- Date modifiied:
- 2017-12-01
Related products to: MDM2 Antibody
Related articles to: MDM2 Antibody
- Primary tumors of the pulmonary artery are rare and often mimic thromboembolic disease, leading to delayed diagnosis with potentially serious consequences. - Source: PubMed
Publication date: 2026/05/05
Matthias ChristophWiedemann ChristianeWaldsperger HannaKommoss Felix K FSchlegel PhilippEden MatthiasGeis NicolasAndré FlorianAbu Sharar HaithamLehmann LorenzFrey NorbertKonstandin MathiasMeder BenjaminSalatzki Janek - Adenomatoid tumor is a rare benign neoplasm of mesothelial origin occurring in various anatomical locations, including the uterus. In this article, we describe an adenomatoid tumor of the uterus exhibiting severe nuclear atypia in the clinical context of long-term hormone therapy. The patient was a 51-year-old woman who underwent total abdominal hysterectomy with bilateral salpingo-oophorectomy for uterine leiomyomas. Gross evaluation of the uterus revealed multiple intramural and subserosal unencapsulated nodules that were both well and poorly circumscribed and measured from 4 to 25 mm. Microscopically, one of the nodules consisted of hyperplastic leiomyocytes intermixed with irregular vascular-like and tubular spaces lined by flattened cells that occasionally showed moderate to severe nuclear atypia (enlargement, hyperchromasia, and multinucleation). Bizarre pleomorphic cells were also present. Mitotic activity was minimal. The tumor cells showed diffuse positivity for calretinin, keratin AE1/AE3, L1 cell adhesion molecule, and podoplanin, while CD31, CD34, epithelial membrane antigen, HMB45, MDM2, and S100 protein stains were negative. Expression of BRCA1-associated deubiquitinase 1 and methylthioadenosine phosphorylase was retained. This immunophenotype supported a mesothelial origin of the neoplastic cells, leading to the final diagnosis of adenomatoid tumor with marked nuclear atypia. Unusual histopathological findings in adenomatoid tumors, such as marked nuclear atypia and pleomorphism, may pose significant diagnostic challenges and result in misdiagnosis. Despite these unusual features, the tumor in our study showed no evidence of aggressive behavior or malignant transformation. Although we hypothesize that these changes may be related to prolonged hormone therapy, their pathogenesis and clinical significance remain unclear, underscoring the need for further investigation. - Source: PubMed
Publication date: 2026/05/05
Lenz JiříMichalová KvětoslavaPtáková NikolaKavka MiroslavSlonková VeronikaČerná JanaFiala Luděk - Retroperitoneal sarcoma (RPS) is a type of malignant tumour arising from mesenchymal tissues within the retroperitoneal space. RPSs tend to develop covertly and are often undiscovered when they have already grown significantly and invaded surrounding tissues and organs. These malignancies demonstrate high recurrence rates, present surgical challenges and exhibit limited responsiveness to radiotherapy and chemotherapy. Serum-derived molecules are known to play critical roles in tumourigenesis and tumour progression. However, the serum molecular profile of RPS patients remains unclear. - Source: PubMed
Xie Fu'anGu LingweiYang KunrongWang ShuaiXiao MengmengYan GuangtingZhang QuanLiang RubingZhuang AoboXi ZheNiu YujiaChen YanhuaXia XiaogangQu LinlinZhao BinLi WeibingWu TingYu ChundongLuo ChenghuaWang HouzhaoLian LanlanLi Wengang - Murine double minute 2 (MDM2) has been implicated in diverse neurological disorders, yet its precise function in the central nervous system remains poorly defined. - Source: PubMed
Publication date: 2026/05/02
Jin YingCui HengzhenKang JunyaChen WenqiZhang ChuanlinZhang ChunHan YunyunMeng Xianfang - Alzheimer's disease (AD) is a multifactorial neurodegenerative disorder with a complex pathological process, in which oxidative stress serves as a key pathogenic mechanism. Studies have shown that the anesthetic adjuvant dexmedetomidine (Dex) can improve postoperative cognitive function in AD patients. This study aimed to explore whether dexmedetomidine alleviates AD-associated neuronal apoptosis and cognitive impairment via reducing overproduction of ROS and regulating the XIAP signaling pathway. - Source: PubMed
Publication date: 2026/04/17
Wu WeiweiWang HuiZhang LuyaoLi DanqingChen YuxiangLin BolinJiang HuiqinMeng TingZhu ZheaoHe LijunZhang HuiLiu HuZhang Ruijie